BDX vs ACU vs RVP Stock Comparison

Becton Dickinson, Acme United and Retractable Technologies Prices as of Nov 4, 2026 Peers: Industry group
1 more company in this comparison (MDLN) Create a free account to keep reading and compare up to 10 companies.
BDX Becton Dickinson & Co
$209.18 +15.8% 1M +16.8% 1Y
Market cap
$56.98B
P/E
61.1x
Revenue (TTM)
$23.25B
Div. yield
2.01%
Medical Supplies Healthcare
4 wins
ACU Acme United Corp
$70.92 +11.2% 1M +88.2% 1Y
Market cap
$271.89M
P/E
27.6x
Revenue (TTM)
$211.60M
Div. yield
0.90%
Medical Supplies Healthcare
8 wins

Head to Head

12 decided of 12

Acme United leads on 8 of the 12 questions below (Acme United 8, Becton Dickinson 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBDXACURVPLeader
Larger companyMarket capitalisation $56.98B $271.89M $17.06M BDX
Cheaper on earningsLower P/E, profitable companies only 61.1x 27.6x -4.7x ACU
Cheaper on forward earningsLower price / next fiscal year consensus EPS 16.1x 25.8x — BDX
Faster revenue growthRevenue growth, trailing twelve months +17.4% +9.0% -11.2% BDX
More profitableNet margin, trailing twelve months 4.0% 4.6% -10.6% ACU
Better return on capitalReturn on invested capital 5.3% 7.3% -31.4% ACU
Less leveragedLower net debt / EBITDA 3.2x 1.1x 2.6x ACU
Higher dividend yieldTrailing dividend yield 2.01% 0.90% — BDX
Better 1-year returnPrice return, last 12 months +16.8% +88.2% -32.2% ACU
Better 5-year returnAnnualised price return, 5 years -3.0%/yr +14.7%/yr -42.5%/yr ACU
Less volatileAnnualised volatility, 1 year 32.2% 30.8% 40.0% ACU
Higher overall scoreMean of the five percentile scores vs peers 67/100 71/100 52/100 ACU

Percentile Scorecard

BDXACURVP

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBDXACURVP
Valuation 88 #28 of 229 94 #14 of 229 72 #64 of 229
Growth 48 #115 of 221 59 #92 of 221 34 #147 of 221
Profitability 77 #49 of 209 81 #41 of 209 38 #131 of 209
Financial Health 27 #176 of 240 57 #104 of 240 66 #82 of 240
Shareholder Returns 97 #6 of 146 62 #56 of 146 –
Overall 67 71 52
  • BDX ranked among 248 companies in Medical Devices and Diagnostics
  • ACU ranked among 248 companies in Medical Devices and Diagnostics
  • RVP ranked among 248 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBDXACURVPSPY
1 month +15.8%+11.2%-18.6% -1.0%
3 months +22.6%+26.6%-14.9% -0.4%
6 months +44.5%+68.0%-17.7% +4.5%
Year to date +7.8%+75.9%-26.2% +12.4%
1 year +16.8%+88.2%-32.2% +13.6%
3 years -19.2%+114.3%-48.6% +76.4%
3 years, per year -6.9%+29.0%-19.9% +20.8%
5 years -14.2%+98.1%-93.7% +63.7%
5 years, per year -3.0%+14.7%-42.5% +10.4%
10 years +19.5%+231.4%-77.6% +267.7%
10 years, per year +1.8%+12.7%-13.9% +13.9%

Risk

MeasureBDXACURVPSPY
Volatility, 1Y 32.2%30.8%40.0% 12.8%
Downside volatility, 1Y 33.2%24.6%44.3% 12.7%
Beta vs S&P 500, 1Y 0.380.240.13 1.00
Return / volatility, 1Y 0.522.87-0.81 1.06
Max drawdown, 5Y -50.4%-41.7%-94.0% -25.4%
From 52-week high -0.4%0.0%-33.5% -1.6%
52-week high $210.02$70.92$0.86 $779.14
52-week low $140.71$35.50$0.56 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBDXACURVP
P/E now vs peer median 61.1xmedian 28.5x 27.6xmedian 28.5x -4.7xmedian 28.5x
P/S now vs peer median 2.5xmedian 2.9x 1.3xmedian 2.9x 0.5xmedian 2.9x
EV/EBITDA now vs peer median 14.7xmedian 18.5x 12.1xmedian 18.5x 1.5xmedian 18.5x
P/FCF now vs peer median 17.8xmedian 26.7x 17.6xmedian 26.7x -3.3xmedian 26.7x
P/B now vs peer median 2.3xmedian 2.3x 2.2xmedian 2.3x 0.2xmedian 2.3x
PEG now vs peer median -4.18median 0.93 0.93median 0.93 0.22median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBDXACURVP
Revenue $23.25B $211.60M $33.90M
Gross profit $10.91B $84.82M -$491.51K
Operating income $2.48B $14.48M -$22.68M
Net income $941.00M $9.82M -$3.37M
Free cash flow $3.20B $15.48M -$5.11M
R&D $1.37B – $682.03K
EPS (diluted) $3.42 $2.37 $-0.12
Cash & equivalents $708.00M $5.04M $2.64M
Total debt $16.81B $32.33M $715.92K
Shares (diluted) 275.16M 4.14M 29.94M
Enterprise value $54.13B $253.92M -$129.34M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBDXACURVP
P/E 61.1x 27.6x -4.7x
P/FCF 17.8x 17.6x -3.3x
P/Operating cash flow 14.4x 10.4x -3.4x
P/S 2.5x 1.3x 0.5x
P/B 2.3x 2.2x 0.2x
P/Tangible book 2.4x 3.1x 0.2x
EV/EBITDA 14.7x 12.1x 1.5x
EV/EBIT 29.4x 20.7x 1.0x
EV/Revenue 3.1x 1.4x -0.7x
EV/FCF 22.8x 19.3x 4.3x
EV/Operating cash flow 18.5x 11.5x 4.5x
PEG (3Y EPS CAGR) -4.18 0.93 0.22

Growth

14 metrics
MetricBDXACURVP
Revenue growth (1Y) 17.4% 9.0% -11.2%
Revenue CAGR (3Y) 6.9% 3.1% -14.7%
Gross profit growth (1Y) 23.7% 11.0% 81.2%
Gross profit CAGR (3Y) 8.5% 8.5% -26.8%
Operating income growth (1Y) 13.0% 3.3% -2.3%
Operating income CAGR (3Y) 3.3% 20.1% -11.7%
Net income growth (1Y) -40.6% -5.1% 61.4%
Net income CAGR (3Y) -17.3% 36.0% -23.9%
EPS growth (1Y) -38.0% -5.9% 59.8%
EPS CAGR (3Y) -14.6% 29.7% -21.9%
Operating cash flow growth (1Y) 43.5% 43.2% 58.8%
Operating cash flow CAGR (3Y) 14.5% 12.0% -16.8%
Free cash flow growth (1Y) 54.2% 26.7% 62.3%
Free cash flow CAGR (3Y) 22.5% 1.5% 20.0%

Profitability

14 metrics
MetricBDXACURVP
Gross margin 46.9% 40.1% -1.4%
EBITDA margin 21.4% 11.7% -43.9%
Operating margin 10.7% 6.8% -66.9%
Pretax margin 8.4% 5.9% -9.9%
Net margin 4.0% 4.6% -10.6%
FCF margin 13.8% 7.3% -15.1%
Operating cash flow margin 17.0% 12.3% -14.6%
Return on equity 3.9% 8.2% -4.7%
Return on assets 1.9% 5.0% -2.4%
Return on invested capital 5.3% 7.3% -31.4%
Return on capital employed 6.0% 8.9% -18.0%
Asset turnover 0.5x 1.1x 0.2x
Cash conversion (OCF / net income) 4.2x 2.7x 1.5x
Stock comp / revenue 1.2% 0.9% –

Financial Health

11 metrics
MetricBDXACURVP
Debt / assets 33.1% 16.1% 0.5%
Debt / equity 0.7x 0.3x 0.0x
Net debt / EBITDA 3.2x 1.1x 2.6x
Debt / FCF 5.2x 2.1x -0.1x
Liabilities / assets 51.9% 39.5% 48.6%
Equity / assets 48.1% 60.5% 51.4%
Interest coverage 4.2x – -278.8x
Current ratio 0.9x 3.2x 4.9x
Quick ratio 0.3x 1.3x 3.7x
Cash ratio 0.1x 0.1x 3.0x
Altman Z-score 2.37 4.56 0.43

Shareholder Returns

7 metrics
MetricBDXACURVP
Dividend yield 2.0% 0.9% –
Net buyback yield 4.4% -0.2% –
Shareholder yield 6.4% 0.7% –
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBDXACURVP
Forward P/E 16.1xFY2026 25.8xFY2026 –
EPS, next fiscal year $12.99FY2026 $2.75FY2026 –
EPS growth, next FY +14.8%FY2026 +10.4%FY2026 –
EPS growth, the year after -2.9% +4.0% –
Revenue, next fiscal year $18.11BFY2026 $217.65MFY2026 –
Revenue growth, next FY -17.1%FY2026 +10.7%FY2026 –
Revenue growth, the year after +11.6% +0.7% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBDXACURVP
Held by institutions 96.1% 73.5% 8.8%
Institutions holding 1,444 84 32
Change in shares held, QoQ +0.6% +1.3% +5.9%
Institutions buying 688 47 10
Institutions selling 545 21 4
Buyers to sellers 1.26 2.24 2.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BDXACURVP
BDX 1.00 0.21 0.02
ACU 0.21 1.00 0.06
RVP 0.02 0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BDX, ACU and RVP?

Becton Dickinson (BDX) is the largest by market capitalisation: Becton Dickinson (BDX) $56.98B, Acme United (ACU) $271.89M, Retractable Technologies (RVP) $17.06M.

Which stock is cheaper, BDX, ACU and RVP?

Acme United (ACU) trades on the lowest price-to-earnings ratio (Becton Dickinson (BDX) 61.1x, Acme United (ACU) 27.6x, Retractable Technologies (RVP) -4.7x). On next year's consensus earnings, Becton Dickinson (BDX) is cheapest (Becton Dickinson (BDX) 16.1x, Acme United (ACU) 25.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Becton Dickinson (BDX) grew revenue fastest over the trailing twelve months: Becton Dickinson (BDX) +17.4%, Acme United (ACU) +9.0%, Retractable Technologies (RVP) -11.2%.

Which company is more profitable?

Acme United (ACU) has the highest net margin (Becton Dickinson (BDX) 4.0%, Acme United (ACU) 4.6%, Retractable Technologies (RVP) -10.6%). On return on invested capital, Acme United (ACU) leads (Becton Dickinson (BDX) 5.3%, Acme United (ACU) 7.3%, Retractable Technologies (RVP) -31.4%).

Which stock has performed better?

Over the past year Acme United (ACU) returned the most: Becton Dickinson (BDX) +16.8%, Acme United (ACU) +88.2%, Retractable Technologies (RVP) -32.2%. Over five years, Acme United (ACU) compounded fastest (Becton Dickinson (BDX) -3.0%/yr, Acme United (ACU) +14.7%/yr, Retractable Technologies (RVP) -42.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Becton Dickinson (BDX) has the highest dividend yield: Becton Dickinson (BDX) 2.01%, Acme United (ACU) 0.90%. Retractable Technologies (RVP) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Acme United (ACU) has been the steadiest (Becton Dickinson (BDX) 32.2%, Acme United (ACU) 30.8%, Retractable Technologies (RVP) 40.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BDX, ACU and RVP?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Acme United (ACU) leads on 8. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.